Position in ALT
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$406,406
+$2,989 QoQ
Shares Held
131,950
+18.1% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 98.48427434634331.ToString("F0")%
Shared 0.ToString("F0")%
None 1.515725653656688.ToString("F0")%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WEALTH EFFECTS LLC holds $11,242,442 across 8 Biotechnology names. ALT ranks #3 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
143,300 | $8,984,910 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
118,350 | $907,744 | |
| 3 | ALT |
Altimmune, Inc.
This page
|
131,950 | $406,406 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
12,000 | $398,640 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
10,100 | $240,683 | |
| 6 | GLUE |
Monte Rosa Therapeutics, Inc.
|
10,099 | $166,128 | |
| 7 | HUMA |
Humacyte, Inc.
|
204,500 | $124,131 | |
| 8 | AUTL |
Autolus Therapeutics plc
|
10,000 | $13,800 |
All Filings in ALT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $406,406 | 131,950 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $403,417 | 111,750 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $225,634 | 59,850 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $122,872 | 31,750 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $154,250 | 30,850 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $236,848 | 32,850 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $215,207 | 35,050 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $249,707 | 37,550 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $149,646 | 14,700 | Shares | Sole | 2024-04-22 | |
| No filing history on record for this holder in this stock. | ||||||